These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31496699)

  • 61. Doxorubicin hydrochloride-oleic acid conjugate loaded nanostructured lipid carriers for tumor specific drug release.
    Zhao S; Minh LV; Li N; Garamus VM; Handge UA; Liu J; Zhang R; Willumeit-Römer R; Zou A
    Colloids Surf B Biointerfaces; 2016 Sep; 145():95-103. PubMed ID: 27137808
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Podophyllotoxin-Loaded Nanostructured Lipid Carriers for Skin Targeting: In Vitro and In Vivo Studies.
    Zhao J; Piao X; Shi X; Si A; Zhang Y; Feng N
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27869698
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects.
    Chen X; Zhang Y; Zhao P; Chen Y; Zhou Y; Wang S; Yin L
    Drug Dev Ind Pharm; 2020 Jan; 46(1):57-69. PubMed ID: 31813288
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
    Shah PP; Desai PR; Channer D; Singh M
    J Control Release; 2012 Aug; 161(3):735-45. PubMed ID: 22617521
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
    Khurana S; Jain NK; Bedi PM
    Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nanostructured oleic acid/polysorbate 80 emulsions with diminished toxicity in NL-20 cell line: Insights of potential drug carriers.
    Pérez-González MLL; González-de la Rosa CH; Pérez-Hernández G; Beltrán HI
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110758. PubMed ID: 31932123
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety and effectiveness of sodium colistimethate-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and in vivo studies following pulmonary and intramuscular administration.
    Pastor M; Basas J; Vairo C; Gainza G; Moreno-Sastre M; Gomis X; Fleischer A; Palomino E; Bachiller D; Gutiérrez FB; Aguirre JJ; Esquisabel A; Igartua M; Gainza E; Hernandez RM; Gavaldà J; Pedraz JL
    Nanomedicine; 2019 Jun; 18():101-111. PubMed ID: 30849549
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug.
    Chinsriwongkul A; Chareanputtakhun P; Ngawhirunpat T; Rojanarata T; Sila-on W; Ruktanonchai U; Opanasopit P
    AAPS PharmSciTech; 2012 Mar; 13(1):150-8. PubMed ID: 22167418
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Histological evaluation of follicular delivery of arginine via nanostructured lipid carriers: a novel potential approach for the treatment of alopecia.
    Yazdani-Arazi SN; Ghanbarzadeh S; Adibkia K; Kouhsoltani M; Hamishehkar H
    Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1379-1387. PubMed ID: 27797271
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chitosan coated nanostructured lipid carriers (NLCs) for loading Vitamin D: A physical stability study.
    Rabelo RS; Oliveira IF; da Silva VM; Prata AS; Hubinger MD
    Int J Biol Macromol; 2018 Nov; 119():902-912. PubMed ID: 30063935
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preclinical safety of topically administered nanostructured lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies.
    Vairo C; Collantes M; Quincoces G; Villullas S; Peñuelas I; Pastor M; Gil AG; Gainza E; Hernandez RM; Igartua M; Gainza G
    Int J Pharm; 2019 Oct; 569():118484. PubMed ID: 31260785
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
    Pardeike J; Weber S; Haber T; Wagner J; Zarfl HP; Plank H; Zimmer A
    Int J Pharm; 2011 Oct; 419(1-2):329-38. PubMed ID: 21839157
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
    Zhao X; Sun Y; Li Z
    Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application.
    Nnamani PO; Hansen S; Windbergs M; Lehr CM
    Int J Pharm; 2014 Dec; 477(1-2):208-17. PubMed ID: 25290810
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
    Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O
    Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil.
    Mendes IT; Ruela ALM; Carvalho FC; Freitas JTJ; Bonfilio R; Pereira GR
    Colloids Surf B Biointerfaces; 2019 May; 177():274-281. PubMed ID: 30763792
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nanostructured lipid carriers for site-specific drug delivery.
    Khosa A; Reddi S; Saha RN
    Biomed Pharmacother; 2018 Jul; 103():598-613. PubMed ID: 29677547
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment.
    Huang R; Li J; Kebebe D; Wu Y; Zhang B; Liu Z
    Drug Deliv; 2018 Nov; 25(1):757-765. PubMed ID: 29528244
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.
    Yuan L; Liu C; Chen Y; Zhang Z; Zhou L; Qu D
    Int J Nanomedicine; 2013; 8():4339-50. PubMed ID: 24235831
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tanshinol borneol ester on nanostructured lipid carriers has longer brain and systemic effector retention and better antioxidant activity in vivo.
    Yuan X; Fei F; Sun H; Xiao C; Zhao X; Zhang Y; Zheng X
    Int J Nanomedicine; 2018; 13():2265-2274. PubMed ID: 29695905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.